Discover 3,133 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,133
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing
for
Prostate Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Male
Age: 65+
Code: NCT05497024
Recruiting
Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer
for
Stage 1 cT1b-T1cN0M0, Triple Negative Breast Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06318897
Phase 2, Recruiting
Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
for
Degenerative Disc Disease, Disc Degeneration,
Location: Shenandoah TX, Tyler TX, Shreveport LA, New Orleans LA,
Sponsor: VIVEX Biologics, Inc.
Sex: All
Age: 22 - 70+
Code: NCT06778447
Recruiting
An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy
for
Thyroid Gland Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT04589624
Phase 1, Recruiting
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
for
High Grade Glioma, Diffuse Intrinsic Pontine Glioma,
Location: Houston TX, Cincinnati OH, Chicago IL, Columbus OH,
Sponsor: Nationwide Children's Hospital
Sex: All
Age: 1 - 39
Code: NCT05843253
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations
for
Metastatic Colorectal Cancer, KRAS G12C Mutations
Location: Houston TX, Boston MA
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06412198
Phase 1, Phase 2, Recruiting
QTX3034 in Patients With KRAS G12D Mutation
for
Solid Tumors
Location: Houston TX, San Antonio TX, Oklahoma City OK,
Sponsor: Quanta Therapeutics
Sex: All
Age: 18+
Code: NCT06227377
Phase 1, Recruiting
Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study.
for
Head and Neck Squamous Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06162377
Recruiting
LET Optimized IMPT in Treating Pediatric Patients With Ependymoma
for
Anaplastic Ependymoma, Ependymoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 0 - 22
Code: NCT03750513
Phase 1, Recruiting
Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study
for
Acute Myeloid Leukemia (AML)
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06811233
Phase 2, Recruiting
A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
for
Brain Tumor
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05342454
Recruiting
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
for
Heart Failure, Acute Heart Failure
Location: Houston TX, Austin TX, Dallas TX, Plano TX,
Sponsor: Colorado Prevention Center
Sex: All
Age: 18+
Code: NCT06008197
Phase 3, Recruiting
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
for
Aplastic Anemia, de Novo Myelodysplastic Syndrome,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT01624805
Phase 2, Recruiting
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
for
Metastatic Prostate Cancer
Location: Houston TX, Austin TX, Grand Rapids MI, Metairie LA,
Sponsor: Janssen Research & Development, LLC
Sex: Male
Age: 18+
Code: NCT06800313
Phase 1, Phase 2, Recruiting
Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer
for
Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Male
Age: 18+
Code: NCT04947254
Phase 2, Recruiting
Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method
for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 21+
Code: NCT05054413
Recruiting
Want a closer look at research in Houston? Read our guide: Clinical Trials in Houston: Why the City Leads the Country